<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
    <!-- Font Awesome -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.9.0/css/all.min.css"
        integrity="sha512-q3eWabyZPc1XTCmF+8/LuE1ozpg5xxn7iO89yfSOd5/oKvyqLngoNGsx8jq92Y8eXJ/IRxQbEC+FGSYxtk2oiw=="
        crossorigin="anonymous" referrerpolicy="no-referrer" />
    <!-- Bootstrap CSS -->
    <link rel="stylesheet" href="css/bootstrap.min.css">
    <!-- Custom CSS -->
    <link rel="stylesheet" href="css/style.css">
</head>

<body>

    <div class="main_page5 position-relative fixedHeight">
        <div class="nav_orange">
            <div class="nav_orange_left">
                <h4 class="GothamBook mb-0">US-MM6: feasibility of long-term proteasome inhibition in multiple myeloma by in-class transition from bortezomib to Ixazomib (Ninlaro)<sup>1</sup></h4>
            </div>
            <div class="nav_orange_right">
                <img src="img/logo_orange.png" alt="">
            </div>
        </div>
        <!-- page 5 middle box -->
            <div class="page5_middle_box page21_middle_box page28_middle_box mt-3 mb-4">
                <div class="page21_middle_left page34_middle_left">
                    <div>
                        <h4 class="txt_orange GothamBook mt-1 mb-4">ORRs WERE 62% AFTER VELCADE-BASED INDUCTION AND 70% AFTER TREATMENT WITH THE IXAZOMIB (NINLARO) REGIMEN (N=84)<sup>1,*</sup></h4>
                        <img class="w-100" src="img/page_38_chart.png" alt="">
                            <div class="page5_btns_sm mt-5 mb-4 d-flex justify-content-end pe-4">
                                <a href="../page39/index.html" class="text-uppercase btn_sm_plus">
                                    <span><i class="fas fa-plus"></i></span>
                                    <p class="mb-0 position-relative">SEE STUDY DESIGN</p>
                                </a>
                            </div>
                    </div>
                </div>
            </div>
            <div class="page21_middle_right page34_middle_right page38_middle_right">
                <div class="page21_blue_box page21_blue_box2 mb-2">
                    <p class="mb-0 pe-4 GothamBold txt_blue fs-14">Preliminary results based on the first <br> 84 patients enrolled in the study <br> (at a median follow-up of 8 months)<sup>1</sup></p>
                </div>
                <div class="page21_blue_box">
                    <p class="mb-0 pe-4 GothamLight fs-11"><strong>86% preliminary 12-month PFS rate (95% CI, 73â€“93)</strong>, both from the start of velcade-based induction and from the start of treatment with <br> the Ixazomib (NINLARO) regimen</p>
                </div>
            </div>
    </div>
        <!--  -->
        
        <div class="page5_middle_box">
            <p class="GothamLight fs-12 dark_secondary mt-3 mb-0 w-100 mb-5"><strong class="GothamBook fs-12">Preliminary safety was consistent with previous Ixazomib (NINLARO) studies (MM1)</strong> <br> <strong class="GothamBook">Study limitation: </strong> study is an open-label trial lacking a comparator arm, which may limit interpretation of the results
            </p>
        </div>
        <div class="page5_middle_box page5_p_sm w-75 mb-3 flex-wrap">
                <p class="GothamLight">*ORR = CR + VGPR + PR. <br>
                    CI = confidence interval; CR = complete response; ORR = overall response rate; PR = partial response; US = United States; VGPR = very good partial response.</p>
            </div>


            <div class="footer_page5">
                <div class="d-flex align-items-end">
                    <div class="page5_btns_md">
                        <a href="../page5/index.html"><p class="mb-0 position-relative">MM1 study design</p></a>
                        <a href="../page6/index.html"><p class="mb-0 position-relative">MM1 patient baseline characteristics</p></a>
                        <a href="../page8/index.html"><p class="mb-0 position-relative">RWE study Hajek et al.</p></a>
                        <a href="../page15/index.html"><p class="mb-0 position-relative">RWE study Terpos et al.</p></a>
                        <a href="../page11/index.html"><p class="mb-0 position-relative">RWE study Chari et al.</p></a>
                        <a href="../page18/index.html"><p class="mb-0 position-relative">RWE study Minarik et al.</p></a>
                        <a href="../page21/index.html"><p class="mb-0 position-relative">MM1 PFS</p></a>
                        <a href="../page23/index.html"><p class="mb-0 position-relative">MM1 PFS in patients with high-risk cytogenetics</p></a>
                        <a href="../page25/index.html"><p class="mb-0 position-relative">MM1 response rate</p></a>
                        <a href="../page28/index.html"><p class="mb-0 position-relative">MM1 PFS in <br> pre-treated patients</p></a>
                        <a href="../page31/index.html"><p class="mb-0 position-relative">MM1 safety data</p></a>
                        <a href="../page34/index.html"><p class="mb-0 position-relative">Dosing</p></a>
                        <a href="../page36/index.html"><p class="mb-0 position-relative">Summary</p></a>
                        <a href="../page38/index.html"><p class="mb-0 position-relative">MM6 data</p></a>
                        <a></a>
                    </div>
                    <div class="footer_inner_nav1 position-static ms-auto bg-transparent p-0">
                        <ul>
                            <li>
                                <a href="../page4/index.html"><img src="img/page_1_footer_icon_1.svg" alt=""></a>
                            </li>
                            <li>
                                <a href="https://onetakeda.app.box.com/s/reg7tviee8telgupc6cccshjet2wqqqh" target="_blank" class="text-uppercase">pi</a>
                            </li>
                            <li>
                                <a href="../page40/index.html" class="text-uppercase">ref</a>
                            </li>
                        </ul>
                    </div>
                </div>
            </div>
    </div>

</body>

</html>